Clinical trials: The rise of IL-2 therapy - a novel biologic treatment for SLE
Nat Rev Rheumatol
.
2016 Dec;12(12):695-696.
doi: 10.1038/nrrheum.2016.173.
Epub 2016 Oct 20.
Authors
Jens Y Humrich
1
,
Gabriela Riemekasten
1
Affiliation
1
University Hospital Schleswig-Holstein, Campus Lübeck, Department of Rheumatology, Ratzeburger Allee 160, 23538 Lübeck, Germany.
PMID:
27761021
DOI:
10.1038/nrrheum.2016.173
No abstract available
Publication types
Comment
MeSH terms
Antibodies, Monoclonal*
Biological Products
Humans
Interleukin-2*
Lupus Erythematosus, Systemic
Rituximab
Substances
Antibodies, Monoclonal
Biological Products
Interleukin-2
Rituximab